[9] Finally, the search continues for serum markers that can act as surrogates for information traditionally provided by the liver biopsy—in particular, the stage of fibrosis. As the ability to ...

Recent research suggests that a new approach could help even patients with advanced forms of fatty liver disease.

Discover how integrating advanced imaging, digital pathology, and molecular analysis, can refine fibrosis staging and ...

Kim and colleagues took advantage of this capability in their investigation of non-alcoholic fatty liver disease, a common disease which can progress to inflammation, fibrosis, and liver failure.

VANCOUVER, Washington, Feb. 06, 2025 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTCQB: CYDY) ("CytoDyn" or the "Company"), a biotechnology company developing leronlimab, a CCR5 antagonist with the potential ...

Semin Liver Dis. 2005;25(1):52-64 ... both HFE mutations and hepatic iron accumulation with advanced degrees of fibrosis in cross-sectional studies. Clearly, the known HFE mutations do not ...